ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-6.5%
5Y CAGR+18.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-6.5%/yr
vs +74.1%/yr prior
5Y CAGR
+18.9%/yr
Recent deceleration
Acceleration
-80.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $104.02M | -27.0% |
| 2024 | $142.47M | -16.3% |
| 2023 | $170.28M | +33.6% |
| 2022 | $127.44M | +52.5% |
| 2021 | $83.56M | +90.9% |
| 2020 | $43.77M | +123.1% |
| 2019 | $19.62M | +41.4% |
| 2018 | $13.87M | - |